Connect with us

Cannabis News

U.S. Senate Committee To Hold Hearing On Benefits Of Psychedelics For Military Veterans

Published

9 months ago

on

The U.S. Senate Commission has heard “alternative therapies” for military veterans, many witnesses expected to discuss therapeutic benefits of psychedelic.

Field hearing will be excluded from Capitol, including the Commission of Veteran Senate Affairs in Montevallo, Alabama, Friday, veteran and psychedelic mental health treatment.

Witnesses are an officer for veteran issues (VA), coalition of veteran health care coalition Adam Marr, Compass pathways at Steve Levine, University of Alabama in Brian Schiefer (SCI-DI).

“This is a call for action. Veterans don’t break the system,” The marijuana moments said on Thursday Thursday. “VA makes some good things, but what they don’t do well are these new innovations and have approaches to bring them.”

Writing the testimony to be submitted to the committee “alternative therapies” said “, therefore,” therapies are being created or psychedelic, psilocybin, dmt, 5-meo-dmt, Methylon. “

“In general, these therapies of psychedelic therapies are also fast and solid symptoms offer rapid and strong improvements.

“Despite the promising results, psychedelic therapies face the regulatory research barriers” and the access said in the testimony. It also said that “difficult understanding” is why federal federations only offered “minimum” funding to support research on therapeutic benefits of substances.

Most witnesses selected hearing They have somehow been psychedelic research and defense.

For example, Ixse Wiechers, Director General of Veterans Health Administration (VHA), was among the authors of a 2024 report among the authors of research on research and implementation of psychedelic research research on VA 2024.

Levine serves as a director of patients compass, a biotechnology research company specializing in Psychodelics, who helped protect a nomination of the Psilocybin of the Food and Drug Administration (FDA).

Schiefer also promotes the therapeutic benefits of psychedelic medicine as the role of SCI-DI to spread access to alternative therapies for veterans with severe mental and physical conditions with severe mental and physical conditions.

Notable, in the situation of a member of the Audition Committee, Tommy Tuberville (R-al), who has provided support for the Canavy Industry Bank But it is not particularly proactive in the face of psychedelic reform.

The meeting of the Senate is broader in Congress carefully to the subject. On both sides of Congress, as well as key officials of the administration to deform reform.

For example, Vako’s head recently He assumed his role to promote access to psychedelic access to veterans With serious mental health conditions, it was possible to open “wider than thought that door”.

VA Secretary Doug Collins, who He has raised attention to the President Donald TrumpHe said, “We will do the right way,” Ibogaine, MDMA and PSilocybin to face the clinical trials that are being investigated.

Last month, the Secretary also confirmed “Very open” to spread access to psychedelic therapy for veterans-Massionate that people with serious mental health conditions intend to find “healing” ways and not only treat surface symptoms.

Collins pointed out that VA is actively performed through internal or private cooperation in clinical trials “actually results in different substances that are good results”, including One is investigating a supported MDMA-based therapy based on VA Bronx health care “Actually, good results.”

In that conversation, it was also Collins He showed the last clip of the army stamps in Rob O’Neill, who killed Osama bin Laden, The federal government intentionally avoided his theory, because he has prevented access to psychedelic medicine, because cures are more profitable than long-term treatments. Collins replied in response: “I will tell you right now: this secretary of veterans, myself, I want to heal people.”

In the meantime, the GOP-controlled household board approved a change attached to the defense invoice “Progress Report” is required in a Psychedelic Pilot Therapy program For active duty for military service members and veterans.

However, the Congress has been a research proposal for psychedelic research in recent sessions, last week, has blocked a change of bipartisan bipartisa (R-TX) that would provide another $ 10 million. Clinical essays in therapeutic potential of substances like ibogaine and psilocybin in the therapeutic potential of clinical support.

–
Marijuana is a moment Monitoring of hundreds of cannabis, psychedelic and drug policy invoices This year’s state legislatures and congresses. Patreon supporters At least $ 25 / monthly enter our interactive maps, graphs and listening to the listening calendar, so they do not lose development.

Learn more about us Marihuana Bill Tracker and become Assistant Patreon to get access.
–

One by one, Bipartisan Congress legislators met with VA secretary Discuss paths to access psychedelic medicine As an alternative treatment for conditions like PTSD.

After Meeting by asking for Collins In May, reps. Lou Correa (D-CA) and Jack Bergman (R-Mi) The chairs of psychedelic psychedelic psychedelic psychedelics (path) Caucus said three.

Collins, in particular, is highlighted as VA Secretariat for Sustnator, which explores the potential of Ubogaine and MDMA, providing relief of serious mental health conditions, Robert F. Kennedy Jr., HHS head, is his goal. Release plant-based medicine options within 12 months.

New Gingrich (R-GA) separated the former speaker of the US Psychedelic Ibogaine is a “amazing breakthrough” The current “patient care system” has left people with serious mental health conditions, unintentionally intended by alternative treatment options, and intends to use its impact on the problem.

One by one, he entered the change of expenditure invoices in Correa and BergmanResearch on the benefits of psychedelic treatment to treat medical conditions It usually affects military veterans.

Legislators separated the bill in April to provide $ 30 million each year Establish psychedelic by the “Centers for Excellence” at VA FacilitiesVeterans to receive an innovative treatment that contains substances such as Psilocybin, MDMA and Ibogaine.

Collins, for his part, also known in April he had “open eye” with Kennedy About the therapeutic potential of psychedelic medicine. And he said that the government is open to the idea of ​​giving boots to cover the costs of psychedelic therapy for veterans who receive external services from VA. As a congress.

Bergman also has Advanced Psychedelic Reform Opportunity to advance through TrumpThe administration argues that federal expenditure and the efforts will give the “spine” agencies to deal with complex problems.

Kennedy, for his part, also said in April Had “wonderful experience” with LSD in 15 yearsHe thought he could see the dinosaurs, as he portrayed in a comic book.

Last October, Kennedy criticized the FDA “Psychodelics Support” of the Agency and said the laundry of other issues.

In December, VA reported individually to finance $ 1.5 million to finance Learn the effectiveness of therapy assisted by MDMA for veterans PTSD and alcohol use disorder (AUD).

Last year, VA Yehuda also financed the initial examination agency “Amazing and strong results” from the first clinical test of MDMA therapy.

In January, Shereef Elnahah Bed secretary was VA (it was very gratifying) Trump said Kennedy Lead HHS protected Psychedelics reform. And he He hoped to work with him For the next administration, but that did not come out.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Become patreon guard!

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

Health Canada opens consultations to deregulate hemp

Published

7 hours ago

on

May 19, 2026

By

Health Canada has published a Notice of Intent to “simplify” the Industrial Hemp Regulation to “eliminate or reduce regulatory burden,” which could include removing the licensing requirement for certain industrial hemp activities, and is asking the industry what changes it wants to see before June 30, 2026.

The announcement acknowledges that “industry stakeholders have advocated for a new approach to regulating industrial hemp that treats it as an agricultural product” and that although industrial hemp and cannabis belong to the same plant family, “the productions and products resulting from the cultivation and processing of industrial hemp are completely different and pose very different risks.” CBD is “non-intoxicating,” the release states, and hemp “has less potential for public health harm and misuse and less public safety concerns compared to cannabis due to its extremely low THC levels.”

© Colin Temple | Dreamstime

Under the current framework, industrial hemp is listed in Schedule 1 of the Cannabis Act along with high-THC cannabis, even if it contains 0.3% THC or less by weight in the flower heads and leaves. To cultivate, sell, import or export seeds or grains, clean seeds, process grains or grow hemp, operators need a separate license for each activity, plus a separate permit for each import or export shipment. Anyone licensed to cultivate the seeds must test the flower heads and leaves for THC concentration, and all cultivated varieties must appear on Health Canada’s List of Approved Crops. Imported seeds also require phytosanitary certification according to CFIA frameworks. Mature stems, non-viable seeds and their derivatives are already out of the field, sitting on tab 2.

The review calls for eliminating or reducing licensing requirements, removing the separate layer of import/export permits, cutting reporting obligations, revamping the List of Approved Crops, reducing or eliminating THC testing requirements and potentially changing the 0.3% THC definition itself. That said, Health Canada is clear that some controls are being left out, specifically to “prevent the illegal cultivation and diversion of cannabis disguised as industrial hemp into an illegal market,” and that international reporting obligations remain an “important consideration.” Extracting CBD from flower heads is also out of scope, as this requires a cannabis processing license under the Cannabis Regulations.

A separate cost-benefit questionnaire goes directly to current IHR licensees, and the responses feed into the regulatory Impact Analysis Statement required by Health Canada before any proposed amendment reaches the Canada Gazette.

Source: magazine.gc.ca

Continue Reading

Cannabis News

Cannabis Advocacy Groups Push Congress For Legalization And Other Reforms Following Trump’s Rescheduling Move

Published

7 hours ago

on

May 19, 2026

By

“Cannabis reform is the hottest topic in American politics, and … Congress is on course to pass a comprehensive legalization bill that targets the release of cannabis prisoners.”

Author: Jack Gorsline, Filter

A national coalition 41 advocacy groups gathered on Capitol Hill for Cannabis Unity WeekA coordinated lobbying blitz pressed a deadlocked Congress to act on federal marijuana deprogramming, criminal law reform, and fair access.

The May 12-14 mobilization brought together unions, veterans, civil liberties advocates, legal experts, industry executives and individuals directly affected by three main demands: federal cannabis legalization, the release of federal cannabis prisoners, and the expungement of civil rights restoration records. The coalition spent three days navigating the halls of both houses of Congress to introduce a comprehensive package of 13 hemp and cannabis reform bills.

The legislative push comes at a critical time. The vast majority of states have legalized medical or adult use of cannabis in some form, and although the Trump administration rescheduled state legal medical marijuana last month, federal law otherwise continues to classify the plant as a Schedule I controlled substance, creating a legal and economic paradox that advocates say can no longer be ignored.

The coalition’s main thrust is the Marijuana Opportunity Reinvestment and Elimination (MORE) Act, introduced as HR 5068. If passed, the MORE Act would completely remove cannabis from the Controlled Substances Act, ending nearly a century of federal prohibition.

The bill’s provisions go beyond simple deprogramming. It aims to eliminate all federal penalties for marijuana activity, establish clear pathways to expungement and reentry, and create community reinvestment with federal cannabis tax revenue. The bill also includes equity measures designed to lower barriers to entry for small and independent businesses trying to navigate the highly capitalized legal market.

“Cannabis reform is a hot topic in American politics, and now that the president has indicated he’s open to reform, it’s up to Congress to pass a comprehensive legislative bill that targets the release of cannabis prisoners who no longer need to be incarcerated,” Jason Ortiz, director of strategic initiatives at the Last Prisoner Project and Co-founder of the Latino Cannabis Alliancehe said The filter.

Ortiz emphasized that the administrative gesture must be supported by specific legislative moves. “The LPP is ready to work with the co-chairs of the Cannabis Caucus and the Cannabis Unity Coalition to pass a comprehensive deprogramming bill like the MORE Act,” he continued, “to finally end the nightmare that has been cannabis prohibition, and create a pathway for all those incarcerated for cannabis offenses to reunify their families and become full members of society.”

A central theme of Unity Week was the disproportionate impact of federal prohibition on minority communities, particularly Latinos. At a May 13 news conference outside the Senate wing of the Capitol, advocates drew a direct line from the anti-immigrant rhetoric of the early 20th century to today’s deportation statistics.

“Buenos dias. My name is Jessica Gonzalez. I’m an Ecuadorian immigrant, attorney, and president of the Latino Cannabis Alliance, a national coalition of Latino advocates, lawyers, organizers, researchers, and storytellers fighting to move our communities from the margins of cannabis politics to the center,” Gonzalez told reporters and lawmakers. “We’re Harry Anslinger’s worst nightmare.”

Anslinger, the first commissioner of the Federal Bureau of Narcotics, weaponized prejudice against Latinos and blacks in the 1930s to secure the initial federal crackdown on cannabis. Gonzalez noted that the structural machinery built at that time continues to operate with remarkable efficiency.

“We’re here because Latinos are the largest immigrant group in the country, and the cannabis industry benefits enormously from Latino consumers and workers because they remain silent on the same policies that make participation by non-citizen Latinos dangerous,” Gonzalez said. “That’s a contradiction we’re here to say out loud. And here’s a number we don’t hear often enough: 70 percent. More than 70 percent of people convicted federally of cannabis possession are classified as Hispanic. That’s not a coincidence, it’s the result of a system that has merged cannabis prohibition and immigration enforcement into a deportation pathway and targeted our families.”

For noncitizens, as well as legal residents, federal convictions or possession of cannabis can result in mandatory deportation without judicial discretion. Gonzalez noted that the Latino Cannabis Alliance refuses to let the economic boom of state-sanctioned cannabis eclipse the human cost of federal action.

“But we have never been a town that accepts the conditions given to us,” said Gonzalez. “My family refused when they left everything they knew and built a life in a foreign country. Our communities refused when prohibition tried to turn our families into criminals and our neighborhoods into evidence. And today, the Latino Cannabis Alliance refuses to deport one more family, silence one more worker, or erase one more community from a movement we’ve always been.”

He continued, “decriminalization is the floor, not the ceiling. We will not forget the deportees. We will not forget the detainees. Our work takes borders, but it begins where this system was built. The ban began with a lie about our people. It will end with the truth we made.”

Business leaders also described the injustice and inequality of the current landscape.

“Cannabis Unity Week is not a celebration of victory, it’s a call to action,” said Susie Plascencia, founder of Latinas in Cannabis and representative of the National Hispanic Cannabis Council. “Thousands of people are still incarcerated for cannabis crimes, families are still living with the consequences of prohibition, and Latino communities remain disproportionately harmed and underrepresented in this industry.”

Today, Plascencia noted, multi-state marijuana operators generate billions of dollars in public markets, but minority-owned independent startups face severe capital constraints due to federal bank restrictions.

“Latino entrepreneurs are among the fastest growing in the country, building businesses despite systemic barriers,” he said., “But in cannabis, many still face limited access to capital, restrictive policies and exclusion from ownership. We’re building it anyway, but we don’t have to build it alone. We’re here to demand federal action… Because equity isn’t just about repairing damage, it’s about investing in the future.”

The broader drug policy reform movement also gave the coalition its institutional weight.

“As MAPS celebrates its 40th anniversary, we are proud to join the Cannabis Unity Coalition to advance the movement for compassionate, evidence-based drug policy,” said Gina Vensel, Community Partnerships Manager for the Multidisciplinary Association for Psychedelic Studies (MAPS).

“This milestone is an opportunity to reflect on the progress made in the War on Drugs case while recognizing the crucial work that still lies ahead, especially around restorative justice,” Vensel said. The filter. “Together, we strive to dismantle stigma, educate our communities, and advocate for meaningful reform. The Cannabis Unity Coalition represents the power of collective action to drive lasting, positive change.”

Beyond the comprehensive scope of the MORE Act, advocates spent time on the Hill educating lawmakers on narrower measures designed to solve immediate practical problems.

Among them is the STATES 2.0 Act (HR 2934), a bipartisan bill that would amend federal law to respect state legal cannabis programs while protecting state-regulated businesses from federal interference and asset forfeiture. Advocates also pushed for the PREPARE Act (HR 2935 / S 3576), which would have created a federal commission charged with designing a comprehensive regulatory framework for the post-prohibition transition.

To address the decades-long decline in political motivation for scientific research, the coalition also sponsored the Evidence-Based Drug Policy Act (HR 3082) to remove barriers that prevent the Office of National Drug Control Policy from conducting objective research on the social impacts of cannabis legalization.

The coalition also focused heavily on “clean slate” initiatives, housing stability and agricultural guidelines. Key legislation in this area includes the Clean Slate Act, a bipartisan measure that mandates the unsealing of certain federal records for nonviolent cannabis convictions to help affected individuals access employment and educational opportunities. Advocates are also championing the Veterans Safe Use of Cannabis for Healing Act and the Veterans Equal Access Act — additional bills to prevent Veterans Affairs benefits from being stripped away if veterans participate in illegal cannabis programs, and to allow VA doctors to prescribe medicinal cannabis in states where it is legal.

Another item on the coalition’s agenda is the Marihuana Federally Assisted Housing Parity Act, a state-enforced measure to protect people in federally assisted housing from eviction or denial of residency based solely on cannabis use. Finally, organizers are seeking clarification on hemp regulations through a series of farm bills.

As the coalition faced a fight against the entrenched Congress leadership, several lawmakers came out of their offices to show solidarity. After the press conference, Representative Ilhan Omar (D-MN) spoke plainly TMZ About changing currents inside the Capitol.

Omar noted that the enormous financial fallout of maintaining prohibition has fundamentally changed the conversation, making fiscal conservatives increasingly open to reform.

“I will say, legalization advocacy doesn’t necessarily mean you’re a user, so everybody can be an advocate … because we understand that it’s not good for us to spend the billions of dollars that we make now incarcerating people for smoking a port,” Omar said.

Omar also suggested that the Hill’s policy positions lag behind private reality. “I think so There are a lot of people in Congress who smoke cannabis“, he said.

As the three-day rally ended, organizers were optimistic, saying the breadth of the 41-group alliance is forcing lawmakers to view cannabis not as a boutique policy issue, but as a critical intersection of labor rights, immigration justice, veterans’ health care and economic equity, among others.

Whether their unity can propel legislative movement in a deeply polarized Congress remains to be seen, but advocates left Washington with a clear message: the floor for decriminalization has been set; the battle for the ceiling of total justice is underway.

This the article Originally published by the author The filteran online magazine that deals with drug use, drug policy and human rights from a harm reduction perspective. Keep the filter on Bluesky, X or Facebookand sign up for their newsletter.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

More cannabis companies join Texas medical marijuana program as list of potentials hits 15

Published

1 day ago

on

May 18, 2026

By











Texas public safety officials have tentatively approved a dozen cannabis providers to join the state’s medical marijuana program. It’s an important step in expanding access to medical cannabis, after lawmakers voted last year to grow the system from three licensed operators to 15, state officials said.

The companies selected cover nearly every corner of Texas, from the Dallas area and the Panhandle to the Rio Grande Valley and West Texas, reflecting what supporters hope will become a statewide network. Among the 12 suppliers selected to move forward in the final approval process are four companies added since December. Then the Texas Department of Public Safety, which oversees the “Compassionate Use Program,” released an initial list of nine conditionally accepted applicants.

When completed, the licenses will allow the companies, many of them based in Texas, to grow, manufacture, store and sell throughout the state.

“DPS will request additional information from these businesses and will not bill the distributor organization licensing fees until additional due diligence evaluations are completed and passed,” DPS officials said in a statement.

Read more at Dallas Morning News










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media